MBX.TO Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Mai 2024 @ 16:42):

Stats
Tagesvolumen	1 500.00
Durchschnittsvolumen	76 504.00
Marktkapitalisierung	46.43M
EPS	$0 ( 2024-02-14 )
Nächstes Ertragsdatum	( $0 ) 2024-05-08
Last Dividend	$0.275 ( 1999-09-02 )
Next Dividend	$0 ( N/A )
P/E	11.33
ATR14	$0 (0.00%)

Microbix Biosystems Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Microbix Biosystems Inc Finanzdaten

Annual	2023
Umsatz:	$16.51M
Bruttogewinn:	$7.48M (45.30 %)
EPS:	$-0.000300

FY	2023
Umsatz:	$16.51M
Bruttogewinn:	$7.48M (45.30 %)
EPS:	$-0.000300

FY	2022
Umsatz:	$19.08M
Bruttogewinn:	$11.12M (58.32 %)
EPS:	$0.0132

FY	2021
Umsatz:	$18.59M
Bruttogewinn:	$11.04M (59.40 %)
EPS:	$0.0280

Financial Reports:

No articles found.

Microbix Biosystems Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Microbix Biosystems Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.10 - No dividend growth expected in the near future

Information

First Dividend	$0.275	1999-09-02
Last Dividend	$0.275	1999-09-02
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.275	--
Avg. Dividend % Per Year	0.00%	--
Score	2.29	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.10
Div. Directional Score	7.60	--

Next Divdend (Est)
(2024-05-02)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

2.29

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
1999	$0	0.00%
2000	$0	0.00%
2001	$0	0.00%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for TSX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
VA.TO	Dividend Junior	2023-06-30	Quarterly	11	1.32%
MKP.TO	Dividend King	2023-09-14	Quarterly	29	6.09%
CXF.TO	Dividend King	2023-09-22	Monthly	13	2.92%
XSUS.TO	Dividend Junior	2023-09-25	Quarterly	6	0.64%
RQK.TO	Dividend Knight	2023-08-23	Monthly	8	1.42%
GWO-PN.TO	Dividend King	2023-08-30	Quarterly	14	1.89%
BDI.TO	Dividend Knight	2023-09-28	Annually	17	0.76%
VUS.TO	Dividend Knight	2023-09-21	Quarterly	13	0.70%
NVEI.TO	Dividend Junior	2023-08-18	Insufficient data to determine frequency	2	0.13%
DXO.TO	Dividend King	2023-09-25	Monthly	7	2.92%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.157	1.500	6.87	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0957	1.200	6.81	8.17	[0 - 0.3]
returnOnEquityTTM	0.144	1.500	9.52	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	8.53	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.99	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	4.60	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.164	-1.500	7.27	-10.00	[0 - 0.6]
interestCoverageTTM	5.12	1.000	9.21	9.21	[3 - 30]
operatingCashFlowPerShareTTM	0.00702	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.000274	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.221	-1.500	9.12	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.558	1.000	4.03	4.03	[0.2 - 0.8]
operatingProfitMarginTTM	0.200	1.000	8.01	8.01	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.159	1.000	-0.226	-0.226	[0.2 - 2]
assetTurnoverTTM	0.611	0.800	9.26	7.41	[0.5 - 2]
Total Score				12.10

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.41	1.000	8.75	0	[1 - 100]
returnOnEquityTTM	0.144	2.50	9.69	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.000274	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00702	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.131	1.500	-4.21	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0427	1.000	-1.431	0	[0.1 - 0.5]
Total Score				3.10

Microbix Biosystems Inc

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.